2001
DOI: 10.1006/cyto.2001.0874
|View full text |Cite
|
Sign up to set email alerts
|

LEUKAEMIA INHIBITORY FACTOR AND INTERLEUKIN 6 INHIBIT SECRETION OF PROLACTIN AND GROWTH HORMONE BY RAT PITUITARY MtT/SM CELLS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 25 publications
0
10
0
Order By: Relevance
“…Among the particularly interesting proteins are the 29-amino acid CRISPP peptide (cancer-associated serine protease protecting peptide), isolated earlier from plasma of cancer patients (24), a proteolytic fragment of the mut S homolog that has been associated with hereditary non-polyposis colon cancer (25), glioma pathogenesis-related protein (26), which is normally overexpressed in brain tumors, the proto-oncogene c-ets-1 (27), oncogene lbc (28), and the novel oncogene DJ1, which has been shown to interact with c-myc and also transform NIH 3T3 cells in cooperation with ras (29). In addition proteins such as the angiotensinogen precursor, the prostatic tumor suppressor Kangai-1 antigen (30), and the cytokines interleukin-15, and leukemia inhibitory factor (31), which is present in serum at a concentration below 10 pg/ml (32), were also identified. * This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No.…”
Section: Discussionmentioning
confidence: 99%
“…Among the particularly interesting proteins are the 29-amino acid CRISPP peptide (cancer-associated serine protease protecting peptide), isolated earlier from plasma of cancer patients (24), a proteolytic fragment of the mut S homolog that has been associated with hereditary non-polyposis colon cancer (25), glioma pathogenesis-related protein (26), which is normally overexpressed in brain tumors, the proto-oncogene c-ets-1 (27), oncogene lbc (28), and the novel oncogene DJ1, which has been shown to interact with c-myc and also transform NIH 3T3 cells in cooperation with ras (29). In addition proteins such as the angiotensinogen precursor, the prostatic tumor suppressor Kangai-1 antigen (30), and the cytokines interleukin-15, and leukemia inhibitory factor (31), which is present in serum at a concentration below 10 pg/ml (32), were also identified. * This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No.…”
Section: Discussionmentioning
confidence: 99%
“…Additional actions of OSM and LIF include the induction of hepatocyte acute phase protein production (Baumann & Wong 1989, Richards et al 1997) and the stimulation of various haematopoietic lineages, mostly in concert with other growth factors (Metcalf 2003, Tanaka & Miyajima 2003. LIF and OSM also stimulate the production of adrenocorticotrophic hormone (ACTH) production in the pituitary (Kim et al 2000, Chesnokova & Melmed 2002, Auernhammer et al 2004 and affect the secretion of PRL and GH (Tomida et al 2001). Moreover, LIF is required for blastocyst implantation (Chen et al 2000, Song et al 2000 and exerts a multitude of proliferative and differentiating effects on various neuronal cell populations (Metcalf 2003).…”
Section: Lif and Osmmentioning
confidence: 99%
“…In addition, MtT/E cells also show PACAP-induced IL-6 secretion [17]. Furthermore, IL-6 and LIF stimulate the growth of MtT/S somatotrope cells and MtT/SM somatomammotrope cells [14,19]. These data show that not only FS cells but also endocrine progenitor cells may facilitate tumor growth through gp130 cytokines.…”
Section: Discussionmentioning
confidence: 68%